Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

VU0155041

Copy Product Info
🥰Excellent
Catalog No. T3565Cas No. 1093757-42-6
Alias VU-0155041, UV0155041

VU0155041 is an effective and positive allosteric modulator/allosteric agonist at mGlu4 receptors (EC50: 798/693 nM, at human/rat).

VU0155041

VU0155041

Copy Product Info
🥰Excellent
Purity: 99.56%
Catalog No. T3565Alias VU-0155041, UV0155041Cas No. 1093757-42-6
VU0155041 is an effective and positive allosteric modulator/allosteric agonist at mGlu4 receptors (EC50: 798/693 nM, at human/rat).
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
2 mg$34In StockIn Stock
5 mg$53In StockIn Stock
10 mg$77In StockIn Stock
25 mg$148In StockIn Stock
50 mg$198In StockIn Stock
100 mg$317In StockIn Stock
200 mg$458In StockIn Stock
1 mL x 10 mM (in DMSO)$58In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.56%
Appearance:Solid
Color:White to Red
Contact us for more batch information

Resource Download

Product Introduction

VU0155041 AI Summary
VU0155041 is an allosteric modulator of the human mGlu4 receptor, exhibiting positive modulation of calcium flux in both CHO cells coexpressing Gqi5 and BHK cells, with Emax values of 127.0% and 120.0%, respectively, relative to glutamate. The compound has EC50 values of 740.0 nM and 750.0 nM for its allosteric modulator activity in the respective assays. Additionally, VU0155041 demonstrates antiviral properties against SARS-CoV-2, inhibiting the SARS-CoV-2 3CL-Pro protease by 17.63% at 20 µM as measured via a FRET assay, and reducing SARS-CoV-2 induced cytotoxicity in VERO-6 cells by 0.43% at 10 µM after 48 hours of exposure, as assessed by high content imaging..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
VU0155041 is an effective and positive allosteric modulator/allosteric agonist at mGlu4 receptors (EC50: 798/693 nM, at human/rat).
Targets&IC50
mGlu4 (rat):693 nM(EC50), mGlu4 (human):798nM(EC50)
SynonymsVU-0155041, UV0155041
Chemical Properties
Molecular Weight316.18
FormulaC14H15Cl2NO3
Cas No.1093757-42-6
SmilesOC(=O)[C@H]1CCCC[C@H]1C(=O)Nc1cc(Cl)cc(Cl)c1
Relative Density.1.429 g/cm3 (Predicted)
Storage & Solubility Information
StorageIn solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 31.6 mg/mL (99.94 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (6.33 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.1628 mL15.8138 mL31.6276 mL158.1378 mL
5 mM0.6326 mL3.1628 mL6.3255 mL31.6276 mL
10 mM0.3163 mL1.5814 mL3.1628 mL15.8138 mL
20 mM0.1581 mL0.7907 mL1.5814 mL7.9069 mL
50 mM0.0633 mL0.3163 mL0.6326 mL3.1628 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy VU0155041 | purchase VU0155041 | VU0155041 cost | order VU0155041 | VU0155041 chemical structure | VU0155041 formula | VU0155041 molecular weight